Kenvue Inc.
KVUE · NYSE
Bulios Fair Price
$15.38
14.0% downside
Current Price
$17.89
According to Bulios Fair Price, KVUE is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation.
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk L. Perry
Employees
21,890
Headquarters
Summit
Upcoming events
Earnings
Upcoming earnings report